Safety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease
Clinical trial NCT00528840 · COMPLETED
Trial details
- NCT number
- NCT00528840
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2008-10-01
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.